SEARCH RESULTS FOR:
Chris Showalter
CEO, LIFEZONE METALS
"Using our Hydromet Technology at Kabanga and producing locally without the Scope 1, 2, and 3 emissions associated with transport, we can provide nickel with ultra-low levels of CO2 emissions."
Mzila Mthenjane
CEO, MINERALS COUNCIL SOUTH AFRICA
"To reclaim our relevance, exploration activities must increase significantly. Our goal should be to account for at least 5% of global exploration budgets once again."
Chile: The Rock Doctor will See You Now
Chile Mining 2024 - Digital Interactive
Drilling, blasting, and laboratories use rock characteristics to maximize yields
Southeast Asia’s Midstream - Petrochemicals
Southeast Asia Chemicals 2024
The elusive “quarter away”
Boris Eykher and Johan Knapp
BE: CEO AND CO-FOUNDER & JK: BUSINESS DEVELOPMENT, ORES AND CONCENTRATES, OPEN MINERAL
"Open Mineral fits well within this ecosystem, combining the trading of raw materials with advanced technology, and aligning with Saudi Arabia's vision to establish a robust industrial base."
Ontario Mining and Toronto's Global Reach 2025 Pre-Release
Featuring insights from over 70 mining industry leaders, the Ontario Mining and Toronto's Global Reach 2025 pre-release edition provides a panoramic view of this ever-changing sector, shining light on the most compelling mining stories from snowy Sudbury to the green hills of Guyana.
John McCluskey
PRESIDENT AND CEO, ALAMOS GOLD
"We are not only replacing reserves as we mine but expanding them, which is rare in the industry."
Lawrie Conway
MANAGING DIRECTOR AND CEO, EVOLUTION MINING
"The priority at Red Lake is to achieve consistency and generate positive cash flow with a margin on every ounce."
Antony Benham
REGIONAL DIRECTOR, MSA ARABIA
"At present, much of our work in KSA focuses on early-stage exploration and resource evaluation simply because the industry has not yet reached the more advanced stages."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
